Canadian application, no grantCanada
Inhibition of serotonin reuptake
CA 2335336 A1 · Owner: Nissen, Jeffrey Scott · Inventors: Audia, James Edmund; Nissen, Jeffrey Scott; Mcdaniel, Stacey Leigh
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides a 3-(bicyclic heteroaryl)-8-azabicyclo3.2.1oct-2enes and 3-(bicyclic heteroaryl)-8-azabicyclo3.2.1octanes which are useful for the inhibition of serotonin reuptake in mammals.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 4, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 4, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 4, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 4, 1999
GrantedNo grant recorded
Term endedJune 4, 2019
Patent numberCA 2335336 A1
Classification (IPC)A61K31/46 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.